[1]
A.-H. Kiessling, J. Nitsch, U. Strouhal, A. Kornberger, A. Zierer, and A. Moritz, “Associated Risk of Recombinant Activated Factor VIIa Application”, HSF, vol. 16, no. 3, pp. E132-E136, Jun. 2013.